Tryptophan Missense Mutation in the Ligand‐Binding Domain of the Vitamin D Receptor Causes Severe Resistance to 1,25‐Dihydroxyvitamin D

In this study, two related young children, brother and sister, exhibited severe vitamin D‐resistant rickets without alopecia. Sequence analysis of the total vitamin D receptor (VDR) cDNA from skin fibroblasts revealed a substitution of the unique tryptophan of the VDR by arginine at amino acid 286 (W286R). Cultured skin fibroblasts of the two patients expressed normal‐size VDR protein (immunocytochemistry and Western blotting) and normal length VDR mRNA (Northern blotting). But, these fibroblasts, as well as COS‐7 cells transfected with the W286R mutant, failed to bind 3H 1,25‐dihydroxyvitamin D3 [1,25(OH)2D3]. The tryptophan substitution did not affect VDR trafficking toward the nucleus but abolished the 24‐hydroxylase gene response to 1,25(OH)2D3, even at 10−6 M concentrations. In conclusion, this case report of a new family with hereditary vitamin D‐ resistant rickets (HVDRR) emphasizes the crucial role of the VDR tryptophan for ligand binding and for transactivation of 1,25(OH)2D3 target genes. It clearly shows the clinical significance of this VDR amino acid for calcium homeostasis and bone mineralization. This observation suggests further that the presence of a stable VDR‐bound ligand may not be obligatory for normal hair follicle development.

[1]  M. Demay,et al.  Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia. , 2001, Endocrinology.

[2]  W. Zhu,et al.  A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets. , 2001, Molecular genetics and metabolism.

[3]  John H. White,et al.  The Unique Tryptophan Residue of the Vitamin D Receptor Is Critical for Ligand Binding and Transcriptional Activation , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  M. Haussler,et al.  Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3. , 2000, Biochemistry.

[5]  H. DeLuca,et al.  Bacterial expression and characterization of the ligand-binding domain of the vitamin D receptor. , 1999, Archives of Biochemistry and Biophysics.

[6]  J. Pike,et al.  The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. , 1999, Endocrine reviews.

[7]  P. Malloy,et al.  The Vitamin D Receptor Gene Start Codon Polymorphism: A Functional Analysis of FokI Variants , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  R. Baron,et al.  Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. , 1998, Endocrinology.

[9]  M. Haussler,et al.  The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  E. Delvin,et al.  Hereditary 1,25‐Dihydroxyvitamin D–Resistant Rickets Due to an Opal Mutation Causing Premature Termination of the Vitamin D Receptor , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  A. Latronico,et al.  A novel nonsense mutation in the first zinc finger of the vitamin D receptor causing hereditary 1,25-dihydroxyvitamin D3-resistant rickets. , 1997, The Journal of clinical endocrinology and metabolism.

[12]  R. Baron,et al.  Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Hewison,et al.  Mutations in the vitamin D receptor gene in three kindreds associated with hereditary vitamin D resistant rickets. , 1997, The Journal of clinical endocrinology and metabolism.

[14]  Y. Taketani,et al.  A Vitamin D Receptor Gene Polymorphism in the Translation Initiation Codon: Effect on Protein Activity and Relation to Bone Mineral Density in Japanese Women , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  R. Bouillon,et al.  Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. , 1997, The Journal of clinical investigation.

[16]  M. Galligan,et al.  Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. , 1996, Molecular endocrinology.

[17]  J. Pike,et al.  Transcriptional activation and dimerization functions in the human vitamin D receptor. , 1996, Molecular endocrinology.

[18]  P. Malloy,et al.  A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets. , 1996, The Journal of clinical endocrinology and metabolism.

[19]  J. Pike,et al.  Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping , 1996, Clinical endocrinology.

[20]  K. Kristjánsson,et al.  Two mutations causing vitamin D resistant rickets: modelling on the basis of steroid hormone receptor DNA‐binding domain crystal structures , 1994, Clinical endocrinology.

[21]  P. Malloy,et al.  Hereditary 1 alpha,25-dihydroxyvitamin D-resistant rickets resulting from a mutation in the vitamin D receptor deoxyribonucleic acid-binding domain. , 1994, The Journal of clinical endocrinology and metabolism.

[22]  K. Kristjánsson,et al.  Tissue resistance to 1,25‐dihydroxyvitamin D without a mutation of the vitamin D receptor gene , 1993, Clinical endocrinology.

[23]  K. Kristjánsson,et al.  Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3. , 1993, The Journal of clinical investigation.

[24]  R. Weiss,et al.  The syndromes of resistance to thyroid hormone. , 1993, Endocrine reviews.

[25]  K. Ozono,et al.  A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D-resistant rickets. , 1993, The Journal of clinical endocrinology and metabolism.

[26]  H. DeLuca,et al.  Vitamin D-dependency rickets type II: truncated vitamin D receptor in three kindreds , 1993, Molecular and Cellular Endocrinology.

[27]  J. Pike,et al.  VITAMIN D RECEPTOR MUTATIONS AND HEREDITARY 1,25-DIHYDROXYVITAMIN D RESISTANT RICKETS , 1991 .

[28]  I. Yokota,et al.  A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. , 1991, American journal of human genetics.

[29]  Z. Hochberg,et al.  The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families. , 1990, The Journal of clinical investigation.

[30]  U. Liberman,et al.  A unique point mutation in the human vitamin D receptor chromosomal gene confers hereditary resistance to 1,25-dihydroxyvitamin D3. , 1990, Molecular endocrinology.

[31]  B. O’Malley,et al.  An ochre mutation in the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D3-resistant rickets in three families. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  B. O’Malley,et al.  Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. , 1988, Science.

[33]  M. Haussler,et al.  Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. , 1988, Endocrinology.

[34]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[35]  C. Ricour,et al.  Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. , 1986, The Journal of clinical investigation.

[36]  Z. Hochberg,et al.  1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents. , 1984, The Journal of clinical endocrinology and metabolism.

[37]  J. Zerwekh,et al.  Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3. , 1983, The Journal of clinical investigation.

[38]  Z. Hochberg,et al.  Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3. , 1982, The Journal of clinical endocrinology and metabolism.

[39]  D. Feldman,et al.  Demonstration of 1,25-dihydroxyvitamin D3 receptors in human skin biopsies. , 1980, The Journal of clinical endocrinology and metabolism.

[40]  A. Norman,et al.  An hydroxylapatite batch assay for the quantitation of 1alpha,25-dihydroxyvitamin D3-receptor complexes. , 1979, Analytical biochemistry.

[41]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[42]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[43]  D. Moras,et al.  The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. , 2000, Molecular cell.